My skepticism re PCVX is mainly regarding VAX-NP, which I've referred to as vaporware. Moreover, I continue to think PCVX will have a tough task commercializing VAX-24, going up against PFE and MRK, although the task could be eased considerably with a Big Pharma partner.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”